Early, aggressive treatment is often recommended for treating moderate to severe rheumatoid arthritis. Do all patients need early, aggressive treatment? Are all patients receiving early, aggressive treatment? Interestingly, study results show they are not. Some doctors may feel a conservative approach is more suitable for certain patients. Some rheumatoid arthritis patients resist aggressive treatments as well.

• Methotrexate for Rheumatoid Arthritis
• What are Biologic Response Modifiers?
• Are Some Patients Unsuitable Candidates for Biologic Drugs?
• Why is Early, Aggressive Treatment Recommended?

A database from the Consortium of Rheumatology Researchers of North America was used to compare treatment plans of patients with elderly-onset rheumatoid arthritis (disease onset after age 60 years) and younger-onset rheumatoid arthritis (disease onset between 40 and 60 years). Study results, which were reported in the Annals of the Rheumatic Diseases (2006;65:1226-1229), indicated that elderly-onset rheumatoid arthritis patients received combination DMARDs (disease-modifying anti-rheumatic drugs) and biologic treatments less frequently than younger-onset patients even though both groups had identical disease duration as well as comparable disease severity and disease activity.

More Related Resources:

• Guide to Rheumatoid Arthritis
• Rheumatoid Arthritis Screening Quiz
• Test Your Knowledge: Rheumatoid Arthritis
• Rheumatoid Arthritis 101: Free E-Course Newsletter
• TNF Blockers for Rheumatoid Arthritis - Infection Risk Assessed in Older Patients

_{Photo by Stan Rohrer (iStockphoto)}